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Priapism is a complication rarely seen in leukemia. We report a 19-year-old man presented with
persistent painful erection of penis for over 24 hours at home. The patient had underwent immediate
irrigation and decompression of priapism by urologist at emergency services of the hospital. This
approach resulted in a ﬂaccid penis later. During hospitalization, peripheral blood smear and bone
marrow aspiration conﬁrmed the diagnosis of chronic myeloid leukemia.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction interventions directed at the penis. We report a case of a youngPriapism is deﬁned as full or partial erection that continues
more than 4 hours beyond sexual stimulation and orgasm or is
unrelated to sexual stimulation.1 Ischemic priapism is marked by
rigidity of the corpora cavernosa with little or no cavernous arterial
inﬂow. In ischemic priapism time dependent changes occur in the
corporal metabolic environment with progressive hypoxia, hyper-
carbia, and acidosis. The patient typically complains of penile pain
after 6e8 hours, and the examination reveals a rigid erection.1
Ischemic priapism accounts for the majority of cases.
Although SCD is a predominant etiology of veno-occlusive pri-
apism cases in the literature, there are awide variety of other causes
ranging from urinary retention to insect bites.1 Hematologic dys-
crasias are also a major risk factor for ischemic priapism. Priapism
may occur in patients with excessive white blood cell counts. The
incidence of priapism in adult male patients with leukemia is 1%e
5%.2 When priapism presents in the oncology setting, evaluation
and management of the predisposing condition must accompanyile).
.
Inc. This is an open access article uadult who presented with priapism as the ﬁrst manifestation of
chronic myeloid leukemia.Case report
A previously healthy 19-year-old man presented to the Uro-
logical emergency services with history of an erect penis of over
24 hours duration (Fig. 1). His penis was erect, painful and swollen
when he arrived at emergency department. There was no history of
trauma, malaise, night sweats, joint pain, and cough. The patient
gave history of two similar previous episodes lasting for few hours
and subsiding on its own in the past 1 month.
The physical examination revealed that the liver was palpable
1e2 cm below the right costal margin, and spleen was 3 cm below
the left costal margin. The conjunctiva appeared pale with no
jaundice. The penis was erect, ﬁrm and tender with superﬁcial
venous engorgement. Laboratory data showed hemoglobin (Hb)
9.2 g/dl, hematocrit 25.7%, white blood count (WBC), 296,800/mm3,
and platelet 936,000/mm3. Serum chemistries were unremarkable.
Treatment of the priapism was initiated by corporal aspiration and
phenylephrine irrigation at the emergency services under the
impression of low ﬂow type priapism because of the history and
physical examination. The erection gradually reduced following
aspirations and washes.nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Clinical photograph of an erect penis.
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services and was diagnosed as a case of chronic myeloid leukemia
on the basis of peripheral blood smear and bone marrow exami-
nation (Fig. 2). The Philadelphia chromosome was illustrated in the
patient. He was started on hydroxyurea tablets at 1.5 g per day and
Imitinib 40 gm per day. Allopurinol 300 mg daily with adequate
hydration was also started for potential tumor lysis syndrome.Discussion
The condition priapism was named after the Greek god Priapus,
thought to be the son of Zeus. It is believed that a jealous Hera or
Aphrodite cast a spell over his mother while pregnant (either
Aphrodite or Chloe) causing Priapus to be born with the afﬂiction
bearing his name and resulting in him being disowned by his
mother.3 Priapism is an urological emergency, which must be
treated early to prevent erectile dysfunction. Priapism is a rare
condition on its own with an incidence of 1.5 cases per 100,000
person-years. Hematological conditions are the cause of 20% of
cases of priapism inmen. Priapism secondary to penilemetastasis is
rare and one of the etiological factors.4 Depending on the case se-
ries, priapism is seen in between 1 and 5% of male patients with all
types of leukemia.2 Of this small overall percentage, chronic
myeloid leukemia (CML) accounts for 50% of all leukemic priapisms.Figure 2. Bone marrow picture of chronic myeloid leukemia (H&E staining) e a) Under low p
increased megakaryocytes with eosinophilic and basophilic myeloid precursors.However, as a presenting feature of CML, priapism is rare in male
patients, occurring in 1e2%. There is a bimodal age distribution in
males of 5e10 and 20e50 years old, but it has been described in all
age groups.1
There is little data available on the correct management of pri-
apism in patients with CML; however the American Urological
Association has published guidelines based on expert panel dis-
cussion and review of the limited data available.5 American Uro-
logical Association strongly recommends that systemic treatment
of an underlying disorder, such as CML, should not be undertaken as
the only treatment for ischemic priapism.5 Intra-cavernous treat-
ment is required, and should be administered concurrently. As
ischemic priapism is a compartment syndrome it requires treat-
ment directed at the penis primarily. Systemic therapies that are
commonly used in CML patients include cytoreductive therapy,
such as high-dose hydroxycarbamide and tyrosine kinase inhibitors
(TKIs), with or without the addition of leukapheresis to reduce
hyperviscosity.3
Therapeutic aspiration (with or without irrigation) or intra-
cavernous injection of sympathomimetics should be initially tried
to treat priapism. A penile block may be performed but is not
necessary. If performed,10e20ml of 1% lignocaine is injected below
the symphysis pubis to block the dorsal nerves to the penis.
A tourniquet is applied to the base of the penis. A 16 or 18 gauge
biovalve intra-venous catheter can be inserted into the corpus
cavernosum laterally through the penile skin, avoiding the ventral
urethra and dorsal neurovasucular bundle. Alternatively, the can-
nula may be inserted through the glans penis into the corpus cav-
ernosum, which reduces skin bruising.3 As the two corpora are
interconnected, unilateral aspiration is sufﬁcient. Twenty to
thirty ml of blood is aspirated, and heparinized saline may be
injected. This may be repeated a few times. Repeated aspirations
over 1 hour may be needed and up to 50 ml of blood can be aspi-
rated. On its own, aspiration has a success rate of approximately
30%.3
Our case is unique as priapism is a complication rarely seen in
leukemia. The importance of prompt diagnosis and treatment of
priapism cannot be overemphasized, as there is deﬁnite incidence
of impotence following this condition. Besides the initial relief of
priapism, the further workup and management of the underlying
disease are more important. In our case, with use of a combined
urological therapy and oncological treatment to priapism, the pa-
tient rapidly had relief of his clinical problem.ower (10), Hypercellular bone marrow. b) Under high power (100), oil immersion e
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